These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 6511766)

  • 21. [Diabetic complications: good metabolic control protects].
    MMW Fortschr Med; 2011 Apr; 153(15):44-5. PubMed ID: 21667560
    [No Abstract]   [Full Text] [Related]  

  • 22. Approaches to treatment of type 2 diabetes.
    Bloomgarden ZT
    Diabetes Care; 2008 Aug; 31(8):1697-703. PubMed ID: 18663234
    [No Abstract]   [Full Text] [Related]  

  • 23. [A compensated type 2 diabetic patient? Fasting blood glucose can be deceptive].
    MMW Fortschr Med; 2004 Feb; 146(7):62. PubMed ID: 15347061
    [No Abstract]   [Full Text] [Related]  

  • 24. Common patient concerns about the use of glucagon-like peptide-1 receptor agonists in diabetes mellitus management.
    Freeman JS; Gavin JR; Spellman CW
    J Am Osteopath Assoc; 2012 Jan; 112(1 Suppl 1):S22-4. PubMed ID: 22267301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Home glucose monitoring makes little difference in type 2 diabetes.
    J Fam Pract; 2005 Nov; 54(11):936. PubMed ID: 16299946
    [No Abstract]   [Full Text] [Related]  

  • 26. Glycaemic control in patients with diabetes and concomitant psoriasis.
    Shalom G; Shapiro J; Dreiher J; Nathan A; Freud T; Comaneshter D; Horev A; Khoury R; Vinker S; Cohen AD
    Br J Dermatol; 2016 Aug; 175(2):428-30. PubMed ID: 26991639
    [No Abstract]   [Full Text] [Related]  

  • 27. Glycaemic control in diabetes.
    Herman W
    Clin Evid; 2002 Jun; (7):529-37. PubMed ID: 12230678
    [No Abstract]   [Full Text] [Related]  

  • 28. [Control of diabetes mellitus].
    Daweke H
    Verh Dtsch Ges Inn Med; 1990; 96():175-82. PubMed ID: 2092437
    [No Abstract]   [Full Text] [Related]  

  • 29. Thirty years of research on the dawn phenomenon: lessons to optimize blood glucose control in diabetes.
    Porcellati F; Lucidi P; Bolli GB; Fanelli CG
    Diabetes Care; 2013 Dec; 36(12):3860-2. PubMed ID: 24265365
    [No Abstract]   [Full Text] [Related]  

  • 30. Vinegar ingestion at bedtime moderates waking glucose concentrations in adults with well-controlled type 2 diabetes.
    White AM; Johnston CS
    Diabetes Care; 2007 Nov; 30(11):2814-5. PubMed ID: 17712024
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hypoglycemia--simply annoying or dangerous?].
    Kern W
    MMW Fortschr Med; 2016 Jun; 158(11):67-70. PubMed ID: 27271419
    [No Abstract]   [Full Text] [Related]  

  • 32. Rosiglitazone in combination with glimepiride plus metformin in type 2 diabetic patients.
    Kiayias JA; Vlachou ED; Theodosopoulou E; Lakka-Papadodima E
    Diabetes Care; 2002 Jul; 25(7):1251-2. PubMed ID: 12087036
    [No Abstract]   [Full Text] [Related]  

  • 33. Case study 1: exploring the pharmacologic agents for treatment of type 2 diabetes.
    Martin CL
    Diabetes Educ; 2007; 33 Suppl 1():6S-13S. PubMed ID: 17272803
    [No Abstract]   [Full Text] [Related]  

  • 34. Intensification of polypharmacy glucose-lowering treatment in type-2 diabetes: when to be cautious?
    Charbonnel B
    Diabetes Res Clin Pract; 2012 Jul; 97(1):3-5. PubMed ID: 22672881
    [No Abstract]   [Full Text] [Related]  

  • 35. Comment on Monnier et al. Magnitude of the dawn phenomenon and its impact on the overall glucose exposure in type 2 diabetes: is this of concern? Diabetes Care 2013;36:4057-4062.
    Carr RD; Alexander CM
    Diabetes Care; 2014 Jul; 37(7):e161-2. PubMed ID: 24963116
    [No Abstract]   [Full Text] [Related]  

  • 36. How do we gauge the success of treatment of diabetes?
    Zimmet P; Bloomgarden ZT
    J Diabetes; 2012 Sep; 4(3):193-4. PubMed ID: 22727202
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of the glycemic effects of rosiglitazone and pioglitazone in triple oral therapy in type 2 diabetes.
    Tran MT; Navar MD; Davidson MB
    Diabetes Care; 2006 Jun; 29(6):1395-6. PubMed ID: 16732030
    [No Abstract]   [Full Text] [Related]  

  • 38. [Not Available].
    Zulewski H
    Ther Umsch; 2017; 74(8):411-416. PubMed ID: 29461143
    [No Abstract]   [Full Text] [Related]  

  • 39. [ADOPT study. Glitazone controls diabetes progression].
    Einecke D
    MMW Fortschr Med; 2007 Jan; 149(1-2):10, 12, 14. PubMed ID: 17619358
    [No Abstract]   [Full Text] [Related]  

  • 40. Response to comment on Monnier et al. Magnitude of the dawn phenomenon and its impact on the overall glucose exposure in type 2 diabetes: is this of concern? Diabetes Care 2013;36:4057-4062.
    Monnier L; Colette C; Dejager S; Owens D
    Diabetes Care; 2014 Jul; 37(7):e163. PubMed ID: 24963117
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.